Product NDC: | 0574-0113 |
Proprietary Name: | Calcium Acetate |
Non Proprietary Name: | CALCIUM ACETATE |
Active Ingredient(s): | 667 mg/1 & nbsp; CALCIUM ACETATE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0574-0113 |
Labeler Name: | Paddock Laboratories, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091561 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110913 |
Package NDC: | 0574-0113-02 |
Package Description: | 200 TABLET in 1 BOTTLE (0574-0113-02) |
NDC Code | 0574-0113-02 |
Proprietary Name | Calcium Acetate |
Package Description | 200 TABLET in 1 BOTTLE (0574-0113-02) |
Product NDC | 0574-0113 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CALCIUM ACETATE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110913 |
Marketing Category Name | ANDA |
Labeler Name | Paddock Laboratories, LLC |
Substance Name | CALCIUM ACETATE |
Strength Number | 667 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient] |